1. Medicine

Category Archives: Medicine

News Express Sting Operation: Ayurvedic doctor’s Allopathy medicine to patients – Video

Posted on by


News Express Sting Operation: Ayurvedic doctor #39;s Allopathy medicine to patients
News Express Sting Operation: Ayurvedic doctor #39;s Allopathy medicine to patients. The clinic is based in Delhi #39;s Karolbagh. In the expose, it was found out th...

By: News Express

Read more here:

News Express Sting Operation: Ayurvedic doctor's Allopathy medicine to patients - Video

Magical Medicine for oboe clarinet bassoon tuba celesta violin composed by David Huang – Video

Posted on by


Magical Medicine for oboe clarinet bassoon tuba celesta violin composed by David Huang
This is a story about a witch cooking magical medicine. In this piece every instrument plays different roles. Violin as the witch clarinet as the bat oboe as...

By: David Huang

Read this article:

Magical Medicine for oboe clarinet bassoon tuba celesta violin composed by David Huang - Video

Northwestern Medicine debuts new prostate test, reducing need for invasive biopsies

Posted on by

PUBLIC RELEASE DATE:

26-Feb-2014

Contact: Bret Coons bcoons@nmh.org 312-926-2955 Northwestern Memorial Hospital

CHICAGO Northwestern Medicine is the first health care provider in the country to offer a new non-invasive blood test for prostate cancer that is nearly three times more accurate than the current standard prostate-specific antigen (PSA) blood test. Known as the Prostate Health Index (phi), the new test's accuracy will effectively remove the need for many men who test positive for elevated PSA levels to undergo a biopsy to achieve a reliable diagnosis.

According to the Centers for Disease Control and Prevention (CDC), prostate cancer is the most common type of non-skin cancer for men in America and is a leading cause of cancer death among men of all races. The most widely used screening test for prostate cancer is currently the PSA test, which measures the blood's level of PSA, a protein that is naturally produced by the prostate gland and is typically increased when cancer is present. While the PSA test is simple and non-invasive, its results can often indicate the possibility of prostate cancer when none is present.

"The PSA test is based on the fact that men with higher levels of the PSA protein are more likely to have prostate cancer," said William Catalona, MD, urologist at Northwestern Medicine and director of the Clinical Prostate Cancer Program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. "The problem is that higher levels of PSA can also be caused by a benign enlargement or inflammation of the prostate, leading to many false-positives for cancer and ultimately unnecessarily invasive biopsies and an increased potential for patient harm."

In 2012, the U.S. Preventive Services Task Force called attention to the heightened risk of unnecessary patient harm caused by false-positives from PSA testing and released a recommendation calling for "a better test and better treatment options" for prostate cancer screening.

Because PSA testing isn't conclusive enough on its own, physicians normally advise men with increased PSA levels in the range of 4-10ng/mL to undergo a prostate biopsy. However, the phi test helps physicians distinguish prostate cancer from benign conditions by utilizing three different PSA markers (PSA, FreePSA and p2PSA) as part of a sophisticated algorithm to more reliably determine the probability of cancer in patients with elevated PSA levels. Because of the substantial increase in accuracy, results of a multi-center clinical study that Catalona led found a 31 percent reduction in unnecessary biopsies due to false-positives as a result of using the phi test.

In addition to being much more accurate and reducing the need for prostate biopsies, the new test also offers patients a screening option that still only requires a simple blood test. The phi test will become available to all healthcare providers within the first quarter of 2014, and was developed by Beckman Coulter and evaluated in a multi-center clinical research study lead by Catalona as the principal investigator.

###

More:

Northwestern Medicine debuts new prostate test, reducing need for invasive biopsies

Family Medicine Is Tops in Osteopathic Match

Posted on by

More osteopathic physicians matched to family medicine than any other medical specialty in the recently completed American Osteopathic Association (AOA) Intern/Resident Registration Program, which matches graduating osteopathic physicians with residency programs nationwide.

"Every year, we take pride in seeing that the majority of osteopathic medical students match into primary care specialties," said Clinton Adams, D.O., a family physician and chair of the AOA Council on Postdoctoral Training, in the press release.

"Now, in the shadow of the (Patient Protection and) Affordable Care Act, more than ever, our country needs primary care physicians to lead health care teams designed to educate patients about healthy lifestyles in order to help prevent disease and to work as partners with that team to develop the best treatment plan when illness does strike."

Also included in the AOA Match numbers were another 968 residency positions that were filled in nonprimary care areas, such as orthopedic surgery, anesthesiology and emergency medicine.

Perry Pugno, M.D., M.P.H., AAFP vice president for education, told AAFP News that the osteopathic Match results were yet another example of how the much-publicized U.S. primary care physician shortage was affecting the career choices of graduating medical students.

"A 10 percent increase in the number of osteopathic students selecting family medicine is indeed gratifying and bodes well for another increase in the number of allopathic students selecting family medicine when the National Resident Matching Program (NRMP) takes place next month," said Pugno.

Although there remains a large unmet need when it comes to the availability of primary care services in the United States, knowing that 25 percent of 2,064 D.O. graduates selected a career in family medicine feels good, said Pugno. "It is definitely a trend shift in the right direction."

The AOA press release pointed out that the number of students training in osteopathic medicine is on the rise. U.S. osteopathic medical schools have increased their class sizes to keep up with demand, and in the fall of 2013, three new osteopathic medical schools opened their doors to students.

The AAFP has been tracking the unprecedented growth of osteopathic medicine. In the AAFP's analysis of the 2013 NRMP Match(www.stfm.org) in the October issue of Family Medicine, authors pointed out that the number of D.O.-granting medical schools grew from 19 schools in 2002 to 37 schools -- including branch campuses and satellite programs -- in 2013.

In the same report, authors noted that osteopathic medical school first-year enrollment nearly doubled between 2002 (2,968) and 2012 (5,627), and predicted enrollment could reach 6,699 by 2017.

Continued here:

Family Medicine Is Tops in Osteopathic Match

Safety’s the most important thing: hear what operators in Medicine Hat have to say – Video

Posted on by


Safety #39;s the most important thing: hear what operators in Medicine Hat have to say
The safety of our employees, contractors and stakeholders is the most important thing we do at Enerplus. Hear what four of our operators, located at our Medi...

By: Enerplus Corporation

Link:

Safety's the most important thing: hear what operators in Medicine Hat have to say - Video

Safety’s the most important thing: Dalton, an Operator B in Medicine Hat – Video

Posted on by


Safety #39;s the most important thing: Dalton, an Operator B in Medicine Hat
The most important thing we do at Enerplus, http://www.enerplus.com, is ensuring the safety of each other -- our employees, contractors and stakeholders. We ...

By: Enerplus Corporation

See original here:

Safety's the most important thing: Dalton, an Operator B in Medicine Hat - Video

Northwestern Medicine awarded more than $8.4 million for chronic rhinosinusitis research

Posted on by

PUBLIC RELEASE DATE:

25-Feb-2014

Contact: Bret Coons bcoons@nmh.org 312-926-2955 Northwestern Memorial Hospital

CHICAGO The Northwestern Medicine Sinus and Allergy Center has received a grant for more than $8.4 million from the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to help advance the understanding of chronic rhinosinusitis (CRS) and the development of new methods for its treatment over the next five years. The grant will fund research by the newly formed Chronic Rhinosinusitis Integrative Studies Program (CRISP), which is comprised of research groups from Northwestern Medicine, The University of Chicago and Geisinger Health System.

CRS is an often debilitating condition that causes pain and congestion in the sinuses due to inflammation from an infection or other irritants that lasts anywhere from more than 12 weeks to several years. According to the U.S. Centers for Disease Control and Prevention (CDC) nearly 30 million Americans suffer from CRS and approximately $6 billion in healthcare costs can be attributed to its treatment annually.

"Treatments for chronic rhinosinusitis have remained largely unchanged for decades and there is a great need for more research," said principal investigator for CRISP Robert P. Schleimer, PhD, who is also chief of the division of allergy-immunology at Northwestern Memorial Hospital and Northwestern University Feinberg School of Medicine. "Many patients with CRS are forced to undergo multiple surgeries to successfully widen or clear their nasal passages. Rhinosinusitis is also the number one reason adults in America are prescribed antibiotics, which is a major cause for the growing number antibiotic resistant strains of infectious diseases."

The program's research will aim to better understand the epidemiology, genetics and pathogenesis of CRS, most of which remain unknown, with the goal that it will ultimately lead to strategies for the development of new, more effective treatment options.

"There has traditionally been a lack of funding for CRS research," said Robert Kern, MD, chair of otolaryngology at Northwestern Memorial and the Feinberg School of Medicine. "I think the NIAID recognizes that there is an unmet need for more CRS research and that our Sinus and Allergy Center is well-equipped to help guide that research since it is composed of otolaryngists, allergists and bench scientists who often don't collaborate at other medical centers."

The research will be supported through July 2018 with grant PAR-10-271 National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID).

###

Read the original post:

Northwestern Medicine awarded more than $8.4 million for chronic rhinosinusitis research

GW's Huda Ayas to Serve as Associate Dean of International Medicine

Posted on by

Contact Information

Available for logged-in reporters only

Newswise WASHINGTON (Feb. 25, 2014) The George Washington University School of Medicine and Health Sciences (SMHS) is pleased to announce that Huda M. Ayas, Ed.D. 06, M.B.A. 98, M.H.S.A. 93, will serve as associate dean for international medicine. Ayas, who has served in a leadership capacity at SMHS for 20 years, is the founder and executive director of the Office of International Medicine Programs (IMP). Through the IMP office, she has established and managed upwards of 125 global partnerships and affiliations in more than 50 countries and has developed and implemented many international medical education and training programs. Today, she manages more than 60 active affiliations.

Dr. Ayas established and developed this office from the ground up, said Jeffrey S. Akman, M.D., Walter A. Bloedorn Professor of Administrative Medicine, Vice President for Health Affairs, and Dean of SMHS. She has developed an international reputation as someone who is extremely dedicated to the health and well-being of our global community through education, training, and development of physicians and other medical professionals. Her leadership has led to the creation of many terrific opportunities for GW students, residents, staff and faculty to have a positive impact on our global community, which is reflected in the tremendous success of the Office of International Medicine Programs."

Within IMP, Ayas and her team have established a vast array of medical education and training programs, including: the M.D. Program for international students, which allows non-U.S. and non-Canadian students to study medicine at SMHS with the understanding that they will return to their home country to provide medical care to its citizens; the Observership Program, which allows international physicians to come to the U.S. for up to 8 weeks of training in a specific area of medicine; the International Residency Training Program, which allows international medical graduates to pursue their clinical training in the U.S.; the International Clinical Electives Program, which allows for the exchange of medical students with our affiliated institutes for 3rd- and 4th-year rotations; the Fellowship Program, which was designed to increase the knowledge and skills of a physician in any subspecialty beyond that of residency training; and, most recently, the Medical Research Fellowship Program. IMP has provided learning opportunities for more than 10,000 international and GW faculty, students, and staff since its establishment in 1994.

Additionally, Ayas serves as the director of the global health track for M.D. students, which is designed to increase intercultural sensitivity and awareness about international health systems, as well as regional diseases, while teaching students to assess the specific health needs of countries at various stages of development. She also serves as the course director of three Interdisciplinary Medicine elective courses in SMHS and as a Professorial Lecturer of Global Health in GWs School of Public Health and Health Services. Outside of GW, Ayas serves as a member of Physicians for Peace Board of Directors, and as an Advisor and Site Visits Surveyor for the GW Medical Education Partnership Initiative (MEPI), which is a program of PEPFAR and NIH to establish a coordinating center that will evaluate progress and improve communication between partnership programs and African institutions in a dozen countries, as well as U.S. medical schools and universities.

Ayas assumed the role of Associate Dean for International Medicine on January 5, 2014.

###

About the GW School of Medicine and Health Sciences:

Founded in 1825, the GW School of Medicine and Health Sciences (SMHS) was the first medical school in the nations capital and is the 11th oldest in the country. Working together in our nations capital, with integrity and resolve, the GW SMHS is committed to improving the health and well-being of our local, national and global communities. smhs.gwu.edu

More here:

GW's Huda Ayas to Serve as Associate Dean of International Medicine

Annals of Internal Medicine tip sheet for Feb. 25, 2014

Posted on by

PUBLIC RELEASE DATE:

24-Feb-2014

Contact: Megan Hanks mhanks@acponline.org 215-351-2656 American College of Physicians

1. U.S. Preventive Services Task Force publishes final recommendation statement on multivitamins to prevent cardiovascular disease and cancer

The United States Preventive Services Task Force (USPSTF) recommends against the use of beta-carotene or vitamin E supplements for the primary prevention of cardiovascular disease or cancer, according to a recommendation statement being published in Annals of Internal Medicine. Researchers conducted a systematic review of the evidence to assess the benefits and harms of using vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer. The evidence suggests that beta-carotene increases risk for lung cancer in people at risk for the disease. New evidence on the use of vitamin E proves that it lacks effectiveness in preventing cardiovascular disease or cancer. Evidence was insufficient to assess the benefits and harms of the use of multivitamins or single- or paired-nutrient supplements (with the exception of beta-carotene and vitamin E) for preventing cardiovascular disease and cancer. About half of U.S. adults report using at least one dietary supplement and about one-third report using a multivitamin-multimineral supplement. Appropriate intake of vitamin and mineral nutrients is essential to overall health. The benefits of vitamin supplementation are uncertain, so it is recommended that Americans get most of their nutrients from foods. Eating a nutrient-rich diet comprised of mostly fruits, vegetables, whole grains, fat-free and low-fat dairy products, and seafood should provide adequate nutrition. However, there may be specific groups of patients with well-defined conditions for whom specific nutrients will provide benefits. The focus of the recommendation is healthy adults without special nutritional needs. This is an update to the USPSTF's 2003 recommendation.

Note: The URL will go live at 5:00 p.m. on Monday, February 24 and can be included in news stories. For an embargoed PDF, please contact Megan Hanks or Angela Collom. To interview an author, please contact Nicole Raisch at newsroom@uspstf.net or 202-572-2044.

2. Patient-Centered Outcomes Research Institute sets prioritized research agenda for managing two diverse conditions

Two articles being published in Annals of Internal Medicine seek to set prioritized research agendas to fill the evidence gaps about two diverse conditions bipolar disorder in young people and ductal carcinoma in situ (DCIS) in women Both conditions present similar challenges to physicians and patients because the diagnosis is often not clear-cut and typical treatments come with a trade-off of benefits and serious side effects. Using a process described by the Patient-Centered Outcomes Research Institute (PCORI), researchers collaborated with various stakeholders including clinical experts, patients, and advocates to identify and rank the important gaps in knowledge that should be the focus of new research. In bipolar disorder, the researchers noted that the condition can be difficult to distinguish from other behavioral disorders among young people. Despite clinical uncertainty, the use of antipsychotic drugs in this population has increased significantly over the past 20 years. Antipsychotics carry a high risk for adverse effects. Looking at the available evidence, researchers identified 23 potential research needs in three areas: the comparative effectiveness of intervention strategies, the effect of antipsychotics on patient-centered outcomes, and the influence of various patient characteristics on the effectiveness of antipsychotics. In DCIS, there is considerable uncertainty about the optimal clinical management of the condition because of the lack of reliable methods for distinguishing DCIS that would never become symptomatic from DCIS that is likely to progress to life-threatening invasive cancer. The researchers identified knowledge gaps that should be addressed by future research, such as the incorporation of patient-centered outcomes, development of better methods to predict risk of invasive cancer, evaluation of a strategy of active surveillance, and testing of decision-making tools.

Note: The URLs will go live at 5:00 p.m. on Monday, February 24 and can be included in news stories. For an embargoed PDF, please contact Megan Hanks or Angela Collom. To speak with a researcher on the papers, please contact Sarah Avery at sara.avery@duke.edu or 919-660-1306.

###

Here is the original post:

Annals of Internal Medicine tip sheet for Feb. 25, 2014

Study of Hispanic/Latino health presents initial findings

Posted on by

PUBLIC RELEASE DATE:

24-Feb-2014

Contact: Kim Newman sciencenews@einstein.yu.edu 718-430-3101 Albert Einstein College of Medicine

February 24, 2014 (BRONX, NY) One in every six people in the U.S. is Hispanic/Latino and as a group they live longer than non-Hispanic whites (81.4 years vs. 78.8 years). Yet, despite their strong representation and relative longevity, little is understood about this group's health conditions and behaviors.

The Hispanic Community Health Study/Study of Latinos (HCHS/SOL), the landmark research study of Hispanic/Latino health funded by the National Institutes of Health (NIH), has released initial findings that show significant variations in disease prevalence and health behaviors among groups with different backgrounds.

Initial Findings

The findings reported by the National Heart, Lung, and Blood Institute (NHLBI), part of the NIH, are the result of the national study that began in 2008. The data is based on interviews conducted with 16,415 study participants at one of four U.S. field centers located in the Bronx, San Diego, Chicago and Miami.

Variation by Background

"While many trends are consistent across all four field sites, there are clear differences between participants in each city and more importantly, between each Hispanic group," said Robert Kaplan, Ph.D., professor of epidemiology & population health and principal investigator for HCHS/SOL at Albert Einstein College of Medicine of Yeshiva University, which established and operates the Bronx field center.

Among the highlights in The Hispanic Community Health Study/Study of Latinos (HCHS/SOL) Data Book: A Report to the Communities:

Visit link:

Study of Hispanic/Latino health presents initial findings


  1. Medicine